1. Communication between oncologists and lymphoma survivors during follow-up consultations: A qualitative analysis. Issue 5 (3rd September 2017) Authors: Franco, Kara; Shuk, Elyse; Philip, Errol; Blanch-Hartigan, Danielle; Parker, Patricia A.; Matasar, Matthew; Horwitz, Steven; Kissane, David; Banerjee, Smita C.; Bylund, Carma L. Journal: Journal of psychosocial oncology Issue: Volume 35:Issue 5(2017) Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non‐Hodgkin's Lymphoma. (26th February 2019) Authors: Reyes, Carolina; Engel‐Nitz, Nicole M.; DaCosta Byfield, Stacey; Ravelo, Arliene; Ogale, Sarika; Bancroft, Tim; Anderson, Amy; Chen, May; Matasar, Matthew Journal: Oncologist Issue: Volume 24:Number 9(2019) Page Start: 1219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer. (22nd February 2019) Authors: Reyes, Carolina; Engel‐Nitz, Nicole M.; DaCosta Byfield, Stacey; Ravelo, Arliene; Ogale, Sarika; Bancroft, Tim; Anderson, Amy; Chen, May; Matasar, Matthew Journal: Oncologist Issue: Volume 24:Number 9(2019) Page Start: 1209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. International Travel Patterns and Travel Risks for Stem Cell Transplant Recipients. Issue 1 (17th October 2014) Authors: Mikati, Tarek; Griffin, Kenneth; Lane, Dakotah; Matasar, Matthew; Shah, Monika K. Journal: Journal of travel medicine Issue: Volume 22:Issue 1(2015) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. International Travel Patterns and Travel Risks for Stem Cell Transplant Recipients. Issue 1 (17th October 2014) Authors: Mikati, Tarek; Griffin, Kenneth; Lane, Dakotah; Matasar, Matthew; Shah, Monika K. Journal: Journal of travel medicine Issue: Volume 22:Issue 1(2015) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient preferences for first-line treatment of classical Hodgkin lymphoma: a US survey and discrete choice experiment. Issue 11 (18th September 2020) Authors: Khan, Niloufer; Feliciano, Joseph; Müller, Kerstin; He, Mary; Tao, Rei; Korol, Ellen; Dalal, Mehul; Rebeira, Mayvis; Matasar, Matthew Journal: Leukemia & lymphoma Issue: Volume 61:Issue 11(2020) Page Start: 2630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. Issue 3 (March 2015) Authors: Moskowitz, Alison J; Schöder, Heiko; Yahalom, Joachim; McCall, Susan J; Fox, Stephanie Y; Gerecitano, John; Grewal, Ravinder; Hamlin, Paul A; Horwitz, Steven; Kobos, Rachel; Kumar, Anita; Matasar, Matthew; Noy, Ariela; Palomba, M Lia; Perales, Miguel-Angel; Portlock, Carol S; Sauter, Craig; Shukl... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. Issue 3 (March 2015) Authors: Moskowitz, Alison J; Schöder, Heiko; Yahalom, Joachim; McCall, Susan J; Fox, Stephanie Y; Gerecitano, John; Grewal, Ravinder; Hamlin, Paul A; Horwitz, Steven; Kobos, Rachel; Kumar, Anita; Matasar, Matthew; Noy, Ariela; Palomba, M Lia; Perales, Miguel-Angel; Portlock, Carol S; Sauter, Craig; Shukl... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study. Issue 8 (August 2022) Authors: Budde, Lihua E; Sehn, Laurie H; Matasar, Matthew; Schuster, Stephen J; Assouline, Sarit; Giri, Pratyush; Kuruvilla, John; Canales, Miguel; Dietrich, Sascha; Fay, Keith; Ku, Matthew; Nastoupil, Loretta; Cheah, Chan Yoon; Wei, Michael C; Yin, Shen; Li, Chi-Chung; Huang, Huang; Kwan, Antonia; Penuel... Journal: Lancet oncology Issue: Volume 23:Issue 8(2022) Page Start: 1055 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Tissue characteristics and anatomic distribution of cardiac metastases among patients with advanced systemic cancer assessed by cardiac magnetic resonance (CMR). Issue 1 (December 2016) Authors: Pun, Shawn; Plodkowski, Andrew; Gupta, Dipti; Lakhman, Yuliya; Halpenny, Darragh; Matasar, Matthew; Chan, Angel; Liu, Jennifer; Steingart, Richard; Weinsaft, Jonathan Journal: Journal of cardiovascular magnetic resonance Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗